Trial comparisons

Response

The first 2 of this page's 20 results. GET /api/comparisons/v1?page=57

{
  "data": {
    "total": 85013,
    "results": [
      {
        "id": "NCT02285998-sae",
        "title": "Flublok Quadrivalent Influenza Vaccine vs Inactivated Influenza Vaccine: serious adverse events",
        "summary": "145 of 4328 against 132 of 4344; risk difference 0.3 points, 95% interval -0.4 to 1.1; NCT02285998, Protective Efficacy of Flublok® Quadrivalent Versus Licensed Inactivated Influenza Vaccine in Adults ≥50 Years of Age",
        "record": "/library/comparisons/NCT02285998-sae",
        "nct_id": "NCT02285998",
        "kind": "serious-adverse-events",
        "participants": 8672,
        "risk_difference": {
          "value": 0.003116032311761524,
          "lower": -0.004315948485632528,
          "upper": 0.010574721748010989
        },
        "group_1": "145 of 4,328",
        "group_2": "132 of 4,344",
        "difference": "0.3 points",
        "interval": "-0.4 to 1.1",
        "trial_title": "Protective Efficacy of Flublok® Quadrivalent Versus Licensed Inactivated Influenza Vaccine in Adults ≥50 Years of Age"
      },
      {
        "id": "NCT05640648-2a72ce86",
        "title": "Standard Implementation Strategy Period vs Enhanced Contact Investigation Intervention Period: TB Yield (Diagnosis and Treatment Initiation)",
        "summary": "36 of 2874 against 187 of 5761; risk difference -2.0 points, 95% interval -2.6 to -1.4; NCT05640648, Human-centered Design and Communities of Practice to Improve Home-based Tuberculosis Contact Investigation in Uganda",
        "record": "/library/comparisons/NCT05640648-2a72ce86",
        "nct_id": "NCT05640648",
        "kind": "outcome",
        "participants": 8635,
        "risk_difference": {
          "value": -0.019933546389787494,
          "lower": -0.0259319801969283,
          "upper": -0.01353214852139834
        },
        "group_1": "36 of 2,874",
        "group_2": "187 of 5,761",
        "difference": "-2.0 points",
        "interval": "-2.6 to -1.4",
        "trial_title": "Human-centered Design and Communities of Practice to Improve Home-based Tuberculosis Contact Investigation in Uganda"
      }
    ],
    "no_events": 33758,
    "columns": [
      {
        "key": "title",
        "label": "Comparison"
      },
      {
        "key": "group_1",
        "label": "With the outcome",
        "under": "group_2"
      },
      {
        "key": "difference",
        "label": "Risk difference, 95% interval",
        "under": "interval"
      },
      {
        "key": "participants",
        "label": "Participants"
      },
      {
        "key": "nct_id",
        "label": "Trial",
        "under": "trial_title"
      }
    ],
    "order": "Most participants first",
    "kinds": {
      "all": 85013,
      "outcome": 33568,
      "serious-adverse-events": 31897,
      "deaths": 19548
    }
  },
  "release": "trial-comparisons-2026-03-23-0.1.0",
  "terms": [
    {
      "source": "ClinicalTrials.gov's posted results, through CTTI's AACT",
      "license": "ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299",
      "notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.",
      "short": "Freely available. Acknowledgement requested"
    },
    {
      "source": "ClinicalTrials.gov",
      "license": "none stated",
      "notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.",
      "short": "None stated"
    }
  ],
  "next": "/api/comparisons/v1?page=58",
  "request_id": "FNTQhOc9g09KpyS3"
}